Vaccine trial resumes as virus continues grim march
Clinical trials of one of the most advanced experimental COVID-19 vaccines resumed Saturday after a brief safety pause, as infection ...
Read moreTag: AstraZeneca
AstraZeneca resumes COVID-19 vaccine trial after UK green light
Pharma giant AstraZeneca on Saturday said it had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, ...
Read more
Questions over Russia vaccine study inconsistencies
Paris—The Lancet medical journal said Thursday it had asked authors of a study on a potential Russian COVID-19 vaccine for ...
Read more
Mexico warns setback in tests could delay vaccine
The Latin American roll-out of a potential Covid-19 vaccine made by AstraZeneca could be set back after the biotech company ...
Read more
AstraZeneca pauses COVID-19 vaccine trial after unexplained illness
Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it ...
Read more
Brazil to become testing ground for coronavirus vaccine
Brazil may be struggling in its battle against the coronavirus, but it is on the cutting edge of vaccine development ...
Read more
AstraZeneca launches Juan Healthy Lung Philippines
AstraZeneca, a leading global biopharmaceutical company, announced the launch of Juan Healthy Lung Philippines—an initiative focused on reducing asthma deaths ...
Read more
AstraZeneca, DENR, Cavinti ink pact
Biopharmaceutical company AstraZeneca has entered into a three-year tripartite agreement with the Department of Environment and Natural Resources and the ...
Read more
Giving lung cancer patients a second breath
Accounting for over 15,000 deaths per year, lung cancer is the leading cause of cancer-related deaths in the Philippines. Despite ...
Read more
Manila Standard website (manilastandard.net), launched in August 2002, extends the newspaper’s reach beyond its traditional readers and makes its brand of Philippine news and opinion available to a much wider and geographically diverse readership here and overseas.